[go: up one dir, main page]

NO20021827D0 - Direkte kompresjons-polymer tablettkjerne - Google Patents

Direkte kompresjons-polymer tablettkjerne

Info

Publication number
NO20021827D0
NO20021827D0 NO20021827A NO20021827A NO20021827D0 NO 20021827 D0 NO20021827 D0 NO 20021827D0 NO 20021827 A NO20021827 A NO 20021827A NO 20021827 A NO20021827 A NO 20021827A NO 20021827 D0 NO20021827 D0 NO 20021827D0
Authority
NO
Norway
Prior art keywords
direct compression
tablet core
polymer tablet
compression polymer
core
Prior art date
Application number
NO20021827A
Other languages
English (en)
Other versions
NO20021827L (no
Inventor
Joseph Tyler
John S Petersen
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Publication of NO20021827D0 publication Critical patent/NO20021827D0/no
Publication of NO20021827L publication Critical patent/NO20021827L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021827A 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne NO20021827L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (en) 1999-10-19 2000-10-13 Direct compression polymer tablet core

Publications (2)

Publication Number Publication Date
NO20021827D0 true NO20021827D0 (no) 2002-04-18
NO20021827L NO20021827L (no) 2002-05-29

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021827A NO20021827L (no) 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne

Country Status (29)

Country Link
EP (1) EP1239837B1 (no)
JP (4) JP4942271B2 (no)
KR (1) KR100794427B1 (no)
CN (1) CN1202812C (no)
AR (1) AR026067A1 (no)
AT (1) ATE286386T1 (no)
AU (1) AU778262B2 (no)
BG (1) BG106626A (no)
BR (1) BRPI0015061B8 (no)
CA (1) CA2387915C (no)
CZ (1) CZ20021344A3 (no)
DE (1) DE60017285T2 (no)
EA (1) EA200200387A1 (no)
EE (1) EE200200209A (no)
ES (1) ES2235969T3 (no)
HK (1) HK1049451B (no)
HU (1) HUP0203334A2 (no)
IL (1) IL149146A0 (no)
IS (1) IS6343A (no)
MX (1) MXPA02003684A (no)
MY (1) MY125495A (no)
NO (1) NO20021827L (no)
NZ (1) NZ518334A (no)
PL (1) PL364888A1 (no)
PT (1) PT1239837E (no)
SK (1) SK5412002A3 (no)
TR (1) TR200201087T2 (no)
TW (1) TWI225413B (no)
WO (1) WO2001028527A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778262B2 (en) * 1999-10-19 2004-11-25 Genzyme Corporation Direct compression polymer tablet core
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
ES2338667T3 (es) 2004-03-30 2010-05-11 Relypsa, Inc. Composiciones de union a iones.
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
US20060276534A1 (en) * 2005-03-17 2006-12-07 Amgen Inc. Methods of decreasing calcification
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
KR101547925B1 (ko) * 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
CA2661987C (en) * 2006-09-01 2012-11-06 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) * 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
CA2735962A1 (en) 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (en) * 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
WO2011047700A1 (en) * 2009-10-22 2011-04-28 Synthon B.V. Pharmaceutical compositions of sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
EP2857006A4 (en) * 2012-06-05 2015-12-30 Takeda Pharmaceutical DRY-COATED TABLET
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU669664B2 (en) * 1991-07-03 1996-06-20 Pharmacia & Upjohn Company Colestipol hydrochloride high-content tablets
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
AU778262B2 (en) * 1999-10-19 2004-11-25 Genzyme Corporation Direct compression polymer tablet core

Also Published As

Publication number Publication date
EP1239837A2 (en) 2002-09-18
BG106626A (bg) 2003-03-31
BR0015061A (pt) 2002-07-23
CN1202812C (zh) 2005-05-25
MXPA02003684A (es) 2002-08-30
JP2016000753A (ja) 2016-01-07
AU1088701A (en) 2001-04-30
BRPI0015061B1 (pt) 2016-03-22
MY125495A (en) 2006-08-30
HK1049451A1 (en) 2003-05-16
ES2235969T3 (es) 2005-07-16
KR100794427B1 (ko) 2008-01-16
IS6343A (is) 2002-04-15
SK5412002A3 (en) 2002-09-10
DE60017285T2 (de) 2005-12-08
AR026067A1 (es) 2002-12-26
CA2387915C (en) 2007-04-17
PL364888A1 (en) 2004-12-27
JP2012067132A (ja) 2012-04-05
ATE286386T1 (de) 2005-01-15
KR20020059629A (ko) 2002-07-13
WO2001028527A3 (en) 2002-01-03
EA200200387A1 (ru) 2002-10-31
JP5903111B2 (ja) 2016-04-13
CN1382041A (zh) 2002-11-27
JP2003512317A (ja) 2003-04-02
DE60017285D1 (de) 2005-02-10
BRPI0015061B8 (pt) 2021-05-25
PT1239837E (pt) 2005-05-31
HUP0203334A2 (hu) 2003-02-28
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
CA2387915A1 (en) 2001-04-26
HK1049451B (zh) 2005-12-16
NZ518334A (en) 2003-08-29
EE200200209A (et) 2003-06-16
IL149146A0 (en) 2002-11-10
JP4942271B2 (ja) 2012-05-30
AU778262B2 (en) 2004-11-25
EP1239837B1 (en) 2005-01-05
NO20021827L (no) 2002-05-29
CZ20021344A3 (cs) 2002-08-14
JP2014065749A (ja) 2014-04-17
WO2001028527A2 (en) 2001-04-26
JP5583110B2 (ja) 2014-09-03

Similar Documents

Publication Publication Date Title
NO20021827D0 (no) Direkte kompresjons-polymer tablettkjerne
DE60042164D1 (de) Kompaktes nadelschutzschild
DE60044622D1 (de) Polymerisationsverfahren
DE60024345D1 (de) Polymerelektrolyt
NO2008005I1 (no) Trabectedin
DE60025897D1 (de) Polymerbindemittel
DE60026459D1 (de) Simethicon enthaltendes Abführmittel
DE60039789D1 (de) Polymerzelle
DE60017202D1 (de) Polymerisationsverfahren
FI991029L (fi) Puristin
DE50009614D1 (de) Pressenpartie
DE50003528D1 (de) Formkörper
NO991364D0 (no) Komprimeringsmaskin
DE69936634D1 (de) Medizinischer Kompressionsartikel
DE50013385D1 (de) Entgasungseinrichtung
DK1239837T3 (da) Polymertabletkerne fremstillet ved direkte kompression
DE60022732T2 (de) Audiokodierung
ZA200202772B (en) Direct compression polymer tablet core.
DE50000416D1 (de) Totpunktschalter
FI4077U1 (fi) Pellettipuristin
FIU990201U0 (fi) Pakkausalusta
FI990823L (fi) Puristin
FI991250L (fi) Puristin
UA3100S (uk) Стійка під гантелі
UA3097S (uk) Стійка під гантелі

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application